The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Risk Management

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Risk Management


Psychiatry related information on Risk Management


High impact information on Risk Management


Chemical compound and disease context of Risk Management


Biological context of Risk Management


Associations of Risk Management with chemical compounds


Gene context of Risk Management


  1. Individualized survival curves improve satisfaction with cancer risk management decisions in women with BRCA1/2 mutations. Armstrong, K., Weber, B., Ubel, P.A., Peters, N., Holmes, J., Schwartz, J.S. J. Clin. Oncol. (2005) [Pubmed]
  2. Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives. Anderssen, S.A., Hjelstuen, A.K., Hjermann, I., Bjerkan, K., Holme, I. Atherosclerosis (2005) [Pubmed]
  3. Lead. Bellinger, D.C. Pediatrics (2004) [Pubmed]
  4. Risk management frameworks for human health and environmental risks. Jardine, C., Hrudey, S., Shortreed, J., Craig, L., Krewski, D., Furgal, C., McColl, S. Journal of toxicology and environmental health. Part B, Critical reviews. (2003) [Pubmed]
  5. Dementia. Part 4: Risk management. Dewing, J., Blackburn, S. Professional nurse (London, England) (1999) [Pubmed]
  6. Risk management in hypertrophic cardiomyopathy. Grace, A.A., Brady, P.A., Shapiro, L.M. Lancet (2001) [Pubmed]
  7. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Tsuyuki, R.T., Johnson, J.A., Teo, K.K., Simpson, S.H., Ackman, M.L., Biggs, R.S., Cave, A., Chang, W.C., Dzavik, V., Farris, K.B., Galvin, D., Semchuk, W., Taylor, J.G. Arch. Intern. Med. (2002) [Pubmed]
  8. Risk management in allergen immunotherapy. Greineder, D.K. J. Allergy Clin. Immunol. (1996) [Pubmed]
  9. Thalidomide use in the US : experience with pregnancy testing in the S.T.E.P.S. programme. Uhl, K., Cox, E., Rogan, R., Zeldis, J.B., Hixon, D., Furlong, L.A., Singer, S., Holliman, T., Beyer, J., Woolever, W. Drug safety : an international journal of medical toxicology and drug experience. (2006) [Pubmed]
  10. Sotalol: a new agent for the treatment of ventricular arrhythmias. Samoil, D., Grubb, B.P., Temesy-Armos, P.N. Am. J. Med. Sci. (1994) [Pubmed]
  11. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program. Brinker, A., Kornegay, C., Nourjah, P. Archives of dermatology. (2005) [Pubmed]
  12. AIS' current role in anesthesiology risk management remains uncertain. Lane, P.E. Anesth. Analg. (2005) [Pubmed]
  13. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Jackson, R., Lawes, C.M., Bennett, D.A., Milne, R.J., Rodgers, A. Lancet (2005) [Pubmed]
  14. Can we ensure the safe use of known human teratogens? Introduction of generic isotretinoin in the US as an example. Honein, M.A., Moore, C.A., Erickson, J.D. Drug safety : an international journal of medical toxicology and drug experience. (2004) [Pubmed]
  15. Risk management strategies in the postmarketing period : safety experience with the US and European bosentan surveillance programmes. Segal, E.S., Valette, C., Oster, L., Bouley, L., Edfjall, C., Herrmann, P., Raineri, M., Kempff, M., Beacham, S., van Lierop, C. Drug safety : an international journal of medical toxicology and drug experience. (2005) [Pubmed]
  16. The Xyrem risk management program. Fuller, D.E., Hornfeldt, C.S., Kelloway, J.S., Stahl, P.J., Anderson, T.F. Drug safety : an international journal of medical toxicology and drug experience. (2004) [Pubmed]
  17. Practitioner acceptance of the dofetilide risk-management program. LaPointe, N.M., Kramer, J.M., Weinfurt, K.P., Califf, R.M. Pharmacotherapy (2002) [Pubmed]
  18. Risk management strategy under the Toxic Substances Control Act and the Federal Insecticide, Fungicide, and Rodenticide Act. Todhunter, J.A. Regulatory toxicology and pharmacology : RTP. (1983) [Pubmed]
  19. Risk management in BRCA1 and BRCA2 mutation carriers: lessons learned, challenges posed. DeMichele, A., Weber, B.L. J. Clin. Oncol. (2002) [Pubmed]
  20. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Tayebjee, M.H., Nadar, S., Blann, A.D., Gareth Beevers, D., MacFadyen, R.J., Lip, G.Y. Am. J. Hypertens. (2004) [Pubmed]
  21. Flying lessons: risk management and the NPSA. Fyle, J., McGlynn, A.G. RCM midwives : the official journal of the Royal College of Midwives. (2002) [Pubmed]
  22. The present and future organisation of Veterinary Services in Asia: the examples of the Republic of Korea and Japan. Ozawa, Y., Chang, K., Yoshida, K., Michino, H. Rev. - Off. Int. Epizoot. (2003) [Pubmed]
  23. Environmental Impact Assessment as a tool for risk management. Ratanachai, C. Toxicology and industrial health. (1991) [Pubmed]
WikiGenes - Universities